Trial intelligence / Profile preview

Comparison of analgesic effects of ketamine versus ketamine + bupivacaine in patients with renal calculi

IRCT2013092612695N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ketamine and bupivacaine in nephrolithiasis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Analgesic effectiveness. Started Mar 2012; status: completed.

02

Drugs

ketaminebupivacaine
03

Conditions

nephrolithiasis

Beyond the preview

Go deeper on IRCT2013092612695N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013092612695N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call